bendroflumethiazide has been researched along with atenolol in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (50.00) | 18.7374 |
1990's | 7 (14.58) | 18.2507 |
2000's | 13 (27.08) | 29.6817 |
2010's | 4 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Amery, A; De Plaen, JF; Fagard, R; Lijnen, P; Missotten, A | 1 |
Wilcox, RG | 2 |
Gudbrandsson, T; Hansson, L | 1 |
Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J | 1 |
Braendli, B; Bucher, HJ; Nager, F; Truniger, B | 1 |
Amery, A; Deplaen, JF; Fagard, R; Lijnen, P; Missotten, A | 1 |
Galloway, DB; Lewis, JA; Petrie, JC; Simpson, WT; Webster, J | 1 |
Blake, S; MacDonald, D | 1 |
Barclay, SC; Gibson, J; Lamey, PJ; Miller, S | 1 |
Barrios, SJ; Casasnovas, JA; de la Fuente, V; Escosa, L; Ferreira, IJ; Marcos, JM; Navarro, A; Pardell, H | 1 |
Petrie, JC; Robb, OJ; Webster, J; Witte, K | 1 |
Webster, J | 1 |
Coope, J; Warrender, TS | 1 |
Blake, S; Carey, M | 1 |
Cappuccio, FP; MacGregor, GA; Markandu, ND; Shore, AC; Tucker, FA | 1 |
Andersen, GS | 3 |
Parnell, L; Ramsay, LE; Waller, PC | 1 |
Conway, J | 1 |
Coope, JR | 1 |
Latham, L; Lorimer, AR; McAreavey, D; McLaren, D; Ramsay, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
Brøns, M; Christensen, CK; Geday, E; Jacobsen, FK; Jensen, SN; Kristensen, BO; Linde, NC | 1 |
Zacharias, FJ | 1 |
Gerrard, L; McDevitt, DG; Wheeldon, NM | 1 |
Bevan, EG; Carmichael, HA; Findlay, JG; Herrick, AL; Lorimer, AR; Murray, GD; Pringle, SD; Reid, JL; Waller, PC; Weir, RJ | 1 |
Antonios, TF; Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA | 1 |
Conroy, C; Johnston, GD; McDermott, BJ; Wilson, R | 1 |
Morgan, TO | 1 |
Donnan, PT; Lim, PO; MacDonald, TM | 1 |
Lim, PO; MacDonald, TM; Tzemos, N | 1 |
Peuhkurinen, K; Risteli, J; Ruskoaho, H; Tokola, H; Uusimaa, P; Vuolteenaho, O; Ylitalo, A | 1 |
Bovet, P; Burnier, M; Madeleine, G; Paccaud, F; Waeber, B | 1 |
Beevers, DG; Blann, AD; Gurney, D; Lip, GY; Spencer, CG | 1 |
Kulschewski, A; Schrader, J | 1 |
Füessl, HS | 1 |
Feely, J; Mahmud, A | 1 |
Blann, AD; Felmeden, DC; Lip, GY; Spencer, CG | 1 |
Rahn, KH | 1 |
Mehlsen, J | 1 |
Brown, MJ; Cockcroft, JR; Dhakam, Z; Mackenzie, IS; McEniery, CM; Wilkinson, IB | 1 |
Campbell, NR; Dahlöf, B; Dobson, JE; Poulter, NR; Sever, PS; Wedel, H | 1 |
Chang, CL; Dahlöf, B; Gupta, AK; Nasothimiou, EG; Poulter, NR; Sever, PS | 1 |
Baksi, AJ; Barron, AJ; Fitzgerald, D; Hughes, AD; Jabbour, RJ; Mayet, J; O'Brien, E; Poulter, N; Sever, P; Sharp, A; Stanton, A; Surendran, P; Thom, S | 1 |
2 review(s) available for bendroflumethiazide and atenolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Old or new antihypertensives--which are better?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors | 2005 |
38 trial(s) available for bendroflumethiazide and atenolol
Article | Year |
---|---|
Relative value of beta blockers and thiazides for initiating antihypertensive therapy. Beta blockers or thiazides in hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypertension; Hypertension, Renal; Male; Patient Compliance; Placebos; Propanolamines | 1976 |
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
Combination therapy with saluretics and atenolol in essential hypertension. Effects on blood pressure, electrolytes and uric acid.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Bendroflumethiazide; Chlorthalidone; Diuretics; Drug Evaluation; Drug Therapy, Combination; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Mefruside; Middle Aged; Propanolamines; Uric Acid | 1979 |
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prazosin; Propranolol; Quinazolines | 1977 |
Combination hypotensive therapy with atenolol, bendrofluazide and hydrallazine.
Topics: Angiotensin II; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Propanolamines; Renin | 1977 |
[Atenelol and bendrofluazide in the treatment of medium and severe hypertension (preliminary report)].
Topics: Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Diastole; Female; Humans; Hypertension; Male; Propanolamines; Systole | 1978 |
Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol.
Topics: Antihypertensive Agents; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Humans; Hypertension; Propanolamines; Renin | 1976 |
Atenolol and bendrofluazide in hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Body Weight; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Placebos; Propanolamines | 1975 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal Development; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 1991 |
[Multicenter study of atenolol, combined with hydralazine and bendroflumethiazide in the treatment of essential, mild, and severe, arterial hypertension].
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Severity of Illness Index | 1989 |
Single doses of enalapril and atenolol in hypertensive patients treated with bendrofluazide.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1987 |
Angiotensin converting enzyme inhibitors in the clinic: first-dose hypotension.
Topics: Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Hypotension; Random Allocation | 1987 |
Randomised trial of treatment of hypertension in elderly patients in primary care.
Topics: Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Primary Health Care; Random Allocation; Smoking | 1986 |
Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
Topics: Adult; Atenolol; Bendroflumethiazide; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Random Allocation | 1986 |
A double-blind study of the blood pressure lowering effect of a thiazide diuretic in hypertensive patients already on nifedipine and a beta-blocker.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation | 1987 |
[Beta-blockers or thiazides for middle-aged and elderly patients with hypertension? A multicenter study in general practice].
Topics: Aged; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Humans; Hypertension; Middle Aged; Potassium Chloride; Random Allocation | 1986 |
Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Prazosin; Random Allocation | 1987 |
Atenolol versus bendroflumethiazide in middle-aged and elderly hypertensives.
Topics: Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Potassium Chloride; Random Allocation | 1985 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
Hypertension in the over-60s.
Topics: Age Factors; Aged; Atenolol; Bendroflumethiazide; Humans; Hypertension; Middle Aged; Propanolamines | 1980 |
The 'third drug' trial: a comparative study of anti-hypertensive agents added to treatment when blood pressure is uncontrolled by a beta-blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 1983 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
Antihypertensive treatment in elderly patients in general practice (preliminary results).
Topics: Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged | 1983 |
Antihypertensive effect of atenolol (100 mg once a day) and methyldopa (250 mg thrice a day). A double-blind cross-over multicentre study.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propanolamines | 1981 |
A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol.
Topics: Antihypertensive Agents; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indapamide; Male; Propanolamines | 1981 |
Central effects of combined bendrofluazide and atenolol administration. A single dose study in normal subjects.
Topics: Adult; Atenolol; Attention; Bendroflumethiazide; Blood Pressure; Diazepam; Double-Blind Method; Flicker Fusion; Humans; Male; Memory, Short-Term; Mental Recall; Psychomotor Performance; Reaction Time | 1993 |
Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Renin; Treatment Outcome | 1993 |
A diuretic is more effective than a beta-blocker in hypertensive patients not controlled on amlodipine and lisinopril.
Topics: Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1996 |
A low dose atenolol/bendrofluazide combination in patients with mild to moderate hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male | 1997 |
Does the Dundee Step Test predict outcome in treated hypertension? A sub-study protocol for the ASCOT trial. Anglo-Scandinavian Cardiac Outcome Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Diuretics; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Perindopril; Predictive Value of Tests; Survival Rate; Treatment Outcome | 2000 |
Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Benzopyrans; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitroprusside; omega-N-Methylarginine; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |
Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Cross-Sectional Studies; Electrocardiography; Female; Hematocrit; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; P-Selectin; Perindopril; Regression Analysis; Single-Blind Method; Treatment Outcome; von Willebrand Factor | 2002 |
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Capsules; Captopril; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Diuretics; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; P-Selectin; Perindopril; Platelet Activation; United Kingdom; Vascular Resistance; von Willebrand Factor | 2007 |
Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension.
Topics: Administration, Oral; Aged; Analysis of Variance; Antihypertensive Agents; Arteries; Atenolol; Bendroflumethiazide; Blood Pressure Determination; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Elasticity; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Perindopril; Probability; Regression Analysis; Risk Assessment; Systole; Treatment Outcome | 2009 |
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Topics: Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Europe; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Perindopril; Proportional Hazards Models; Treatment Outcome | 2009 |
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.
Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Diuretics; Drug Resistance; Female; Humans; Hypertension; Ireland; Male; Middle Aged; Perindopril; Risk Factors; Scandinavian and Nordic Countries; United Kingdom | 2011 |
Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Echocardiography, Doppler; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Perindopril; Time; Treatment Failure; Ventricular Function, Left; White People | 2014 |
8 other study(ies) available for bendroflumethiazide and atenolol
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Grinspan's syndrome: a drug-induced phenomenon?
Topics: Aged; Aged, 80 and over; Atenolol; Bendroflumethiazide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Female; Furosemide; Glipizide; Humans; Hypertension; Lichen Planus; Metformin; Middle Aged; Mouth Diseases; Spironolactone; Syndrome | 1990 |
Atenolol, bendrofluazide and their use in combination.
Topics: Antihypertensive Agents; Atenolol; Bendroflumethiazide; Drug Therapy, Combination; Humans; Hypertension; Treatment Outcome | 1998 |
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Bendroflumethiazide; Cardiomegaly; Endothelin-1; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Perindopril; Procollagen; Randomized Controlled Trials as Topic | 2001 |
Monitoring one-year compliance to antihypertension medication in the Seychelles.
Topics: Adult; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Cross-Sectional Studies; Drug Monitoring; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Male; Middle Aged; Office Visits; Patient Compliance; Self Administration; Seychelles | 2002 |
[Antihypertensive therapy: campaign of the giants].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Survival Analysis | 2005 |
[Treating essential hypertension. Are beta blockers still first choice?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Coronary Disease; Drug Therapy, Combination; Humans; Hypertension; Multicenter Studies as Topic; Myocardial Infarction; Outcome Assessment, Health Care; Perindopril; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Stroke | 2007 |
[Hypertension--does it matter how blood pressure is lowered?].
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Bendroflumethiazide; Cardiovascular Diseases; Cost-Benefit Analysis; Diuretics; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Heptanoic Acids; Humans; Hypertension; Perindopril; Pyrroles; Treatment Outcome | 2008 |